Pelvic inflammatory disease laboratory findings

Pelvic inflammatory disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Pelvic Inflammatory Disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pelvic inflammatory disease laboratory findings On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pelvic inflammatory disease laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pelvic inflammatory disease laboratory findings
CDC on Pelvic inflammatory disease laboratory findings
Pelvic inflammatory disease laboratory findings in the news
Blogs on Pelvic inflammatory disease laboratory findings
to Hospitals Treating Pelvic inflammatory disease
Risk calculators and risk factors for Pelvic inflammatory disease laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

There is no specific laboratory findings for PID. Elevated ESR and CRP are suggestive for diagnosis but are not specific. NAAT must be performed to confirm the presence of N. gonorrhoeae and/or C. trachomatis.

Laboratory findings

• There is no specific laboratory findings for PID. Elevated CRP and ESR are non specific findings. Leukocytosis is another findings.
• Laboratory confirmation of Chlamydia, Gonorrhea and/or Mycoplasma genitalium in cervical discharge is helpful to guide treatment.
• All patients with suspected pelvic inflammatory disease should undergo cervical or vaginal nucleic acid amplification tests for N. gonorrhoeae and C. trachomatis infection.
• Vaginal fluid should be evaluated for increased numbers of white cells (more than one neutrophil per epithelial cell) and signs of bacterial vaginosis.
• Pregnancy test should be routinely requested to help rule out ectopic pregnancy.
• Serologic testing for human immunodeficiency virus (HIV) should be performed.